Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease

Figure 4

The diagnostic value of serum CTRP9 level in discriminating well-developed coronary collateralization in patients with different glycometabolic status (a). Different models for evaluating the formation of well-developed collateralization in nondiabetic patients (b). Established model include HR, type of CAD, hyperlipidemia, T2DM, MetS, eGFR, HDL-C, Log hs-CRP, diseased artery associated with the collateralization, SYNTAX score, and CTO lesion. Abbreviations: CTRP9: C1q/tumor necrosis factor-related protein 9; AUC: area under the curve; HR: heart rate; CAD: coronary artery disease; T2DM: type II diabetes mellitus; MetS: metabolic syndrome; eGFR: estimated glomerular filtration rate; HDL-C: high density lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein; CTO: chronic total occlusion.

(a)

(b)